Abstract
The identification and treatment of psychiatric comorbidity in patients undergoing solid organ transplantation present a unique opportunity for psychiatric involvement in the care of medically complex patients. The burden of psychiatric illness in patients awaiting transplant and following transplant is significant and associated with potential morbidity and mortality. Possibilities for psychiatric liaison with our colleagues in transplant medicine and surgery start with the comprehensive psychiatric evaluation that is often performed with potential organ recipients and donors. The vital role of the psychiatrist continues following transplantation, as adjustment is often a stressful experience with associated psychiatric comorbidity. The treatment of psychiatric illness in patients following transplantation requires an understanding of the immunosuppressant medications that patients may be taking, coupled with an awareness of the associated risks of adverse effects and drug-drug interactions.
Original language | English (US) |
---|---|
Pages (from-to) | 398-406 |
Number of pages | 9 |
Journal | Harvard Review of Psychiatry |
Volume | 17 |
Issue number | 6 |
DOIs | |
State | Published - Dec 15 2009 |
Keywords
- Anxiety
- Depression
- Immunosuppressant medications
- Organ transplantation
- Psychiatry
ASJC Scopus subject areas
- Psychiatry and Mental health